Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients with Eosinophil Phenotype.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
85 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Xiaopeng Wang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal